AI
ARK Investment Management LLC disclosed a 8.4% stake in RXRX
ARK Investment Management LLC reported owning 8.4% of Recursion Pharmaceuticals, Inc. (RXRX) (44,745,024 shares) in a Schedule 13G filed Nov 13, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Nov 13, 2026
- Source
- Schedule 13G